Sponsor pipeline

Thomas Ernst, PD Dr. med. clinical trial pipeline

Get alerts when Thomas Ernst, PD Dr. med.'s trials change

1 active trials 0 recruiting 2 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-08-19
Primary completion pushed: 2026-01-31 → 2026-05-31
Trial completed
Completion pushed: 2026-01-31 → 2026-05-31
NCT05701215 Venetoclax After TKI to Target Persisting Stem Cells in CML · Phase 2

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-08-27 NCT07789574 Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations Phase 2 Active, Not Recruiting

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07789574 Efficacy of Asciminib in Chronic Phase CML Patients With T315I Mutations Chronic Myeloid Leukemia (CML) Active, Not Recruiting 2026-08-27

Disease areas by active trials

Chronic Myeloid Leukemia (CML) (1) · Leukemia (1)

Get alerts when Thomas Ernst, PD Dr. med.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free